To highlight current advances in treatments that target the molecular causes of atopic dermatitis is the purpose of this study. Current developments in understanding the molecular basis of atopic dermatitis are leading to the classification of various atopic dermatitis phenotypes. New treatments allow for the targeting of particular molecules implicated in the pathogenesis of atopic dermatitis. Current experimental therapeutics attempt to regulate particular inflammatory pathways linked with various atopic dermatitis phenotypes, which might lead to the creation of customized, targeted-specific atopic dermatitis treatments.

Although the demand to treat atopic dermatitis in good tolerance, efficacy and customization is unfulfilled, the present conventional therapies of atopic dermatitis do not focus on the pathogenesis of the illness as a whole. The development of tailored, phenotypic therapy can open up a hopeful new age of customized therapy for atopic dermatitis.